Abstract
HomeStrokeVol. 51, No. 11Correction to: PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibition and Stroke Prevention: Another Step Forward Free AccessCorrectionPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessCorrectionPDF/EPUBCorrection to: PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibition and Stroke Prevention: Another Step Forward Originally published26 Oct 2020https://doi.org/10.1161/STR.0000000000000352Stroke. 2020;51:e348This article corrects the followingPCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibition and Stroke PreventionIn the article by Alberts and Thompson, “PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibition and Stroke Prevention: Another Step Forward,” which published online on April 21, 2020 (Stroke. doi: 10.1161/STROKEAHA.120.028567) a correction is needed.On page 1361, paragraph one, reads “…FOURIER trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk; Improved Reduction of Outcomes: Vytorin Efficacy International Trial)….” It should read “FOURIER trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)….”Paragraph two reads “The current report focuses on reduction in stroke events seen in high-risk patients treated with PCSKi evolocumab….” It should read, “The current report focuses on reduction in stroke events seen in high-risk patients treated with the PCSKi evolocumab….”In addition, typos of FOURIER and evolocumab were corrected throughout the article.This correction has been made to the current online version of the article, which is available at https://www.ahajournals.org/doi/10.1161/STROKEAHA.120.028567. Previous Back to top Next FiguresReferencesRelatedDetailsRelated articlesPCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibition and Stroke PreventionMark J. Alberts, et al. Stroke. 2020;51:1361-1362 November 2020Vol 51, Issue 11 Advertisement Article InformationMetrics © 2020 American Heart Association, Inc.https://doi.org/10.1161/STR.0000000000000352PMID: 33104492 Originally publishedOctober 26, 2020 PDF download Advertisement
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
